3 withdrawn, 2 completed, 1 terminated. 4 Phase 3, 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Withdrawn 3, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Withdrawn 2 |
Follow Advicenne Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study, to Evaluate the Effect of ADV7103 on Gastric pH Under Fed and Fasting Conditions in Adult Healthy Participants. ADV7103 - EFFECT OF ADV7103 ON GASTRIC PH, Distal Renal Tublular Acidosis | Phase 1 | Completed | Advicenne Pharma | 12 | 2025-02-25 | 2026-03-10 |
| Study Evaluating Patients With Cystinuria ADV7103, Standard of Care - Cystinuria | Phase 2 / Phase 3 | Withdrawn | Advicenne Pharma | 2024-05-01 | 2024-03-12 | |
| Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children ADV7103, Placebo - Cystinuria | Phase 2 / Phase 3 | Withdrawn | Advicenne Pharma | 2024-03-01 | 2026-01-08 | |
| Extension Study in Primary Distal Renal Tubular Acidosis ADV7103 - Acidosis, Renal Tubular | Phase 3 | Withdrawn | Advicenne Pharma | 2023-12-20 | 2026-02-09 | |
| Study Evaluating Subjects With Distal Renal Tubular Acidosis ADV7103, Placebo - Distal Renal Tubular Acidosis | Phase 3 | Terminated | Advicenne Pharma | 3 | 2021-09-20 | 2026-06-03 |
| Pharmacokinetics and Tolerability of Sulthiame Sulthiame - Epilepsy | Phase 1 | Completed | Centre Hospitalier Universitaire Vaudois | 4 | 2018-02-12 | 2020-02-18 |
Acidosis, Renal Tubular (2) · Cystinuria (2) · Epilepsy (1)
Potassium Citrate (2) · potassium bicarbonate (2) · Standard of Care (1) · sulthiame (1)
France (3) · Belgium (2) · United States (2) · Canada (1) · Switzerland (1)
Adrian J Hapner, MD, PhD (1) · Andre Ulmann, M.D., Ph.D. (1) · Laurence Greenbaum, MD, Ph.D. (1)